Supporting US healthcare providers for successful vaccine communication DOI Creative Commons

Amanda J Pierz,

Lauren Rauh, Dima Masoud

et al.

BMC Health Services Research, Journal Year: 2023, Volume and Issue: 23(1)

Published: May 2, 2023

Abstract Background While many healthcare providers (HCPs) have navigated patients’ vaccine concerns and questions prior to the rollout of COVID-19 vaccines, sentiments surrounding vaccines presented new distinct challenges. Objective To understand provider experience counseling patients about vaccinations, aspects pandemic environment that impacted trust, communication strategies found supportive patient education. Methods 7 focus groups were conducted recorded during December 2021 January 2022, at height Omicron wave in United States. Recordings transcribed, iterative coding analysis was applied. Results 44 group participants representing 24 US states with majority (80%) fully vaccinated time data collection. Most doctors (34%) or physician’s assistants nurse practitioners (34%). The negative impact misinformation on patient-provider both intrapersonal interpersonal levels as well barriers facilitators uptake are reported. People sources play a role health (“messengers”) persuasive messages behavior attitudes towards vaccination (“messages”) described. Providers expressed frustration need continuously address clinical appointments among who remained unvaccinated. Many value resources provided up-to-date evidence-based information guidelines continued change. Additionally, indicated patient-facing materials designed support education not frequently available, but they most valuable changing environment. Conclusions decision-making is complex hinges diverse factors such care access (i.e., convenience, expense) individual knowledge, can major navigating these their patients. But strengthen promote uptake, comprehensive infrastructure must be sustained dyad. findings provide recommendations maintain an facilitates effective provider-patient community, organizational policy levels. There for unified multisectoral response reinforce settings.

Language: Английский

COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic DOI Creative Commons
Kuldeep Dhama, Khan Sharun, Ruchı Tıwarı

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2021, Volume and Issue: 17(10), P. 3495 - 3499

Published: June 30, 2021

The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global coverage that will help control the pandemic. Therefore, individuals who are reluctant be vaccinated or forego COVID-19 can delay progress of overall coverage, leading slower rates and may create obstacles in efforts circulation SARS-CoV-2 as unvaccinated act reservoirs could further outbreaks. Vaccine hesitancy is one major threats directly impact health it challenges our ability eradicate infectious diseases significant herd immunity through vaccination. One strategies counter vaccine follow a multisectoral approach involves collaboration between various stakeholders, such government, private companies, religious groups, other agencies, leverage knowledge, expertise, resources, thereby enabling creation longstanding public trust vaccines.

Language: Английский

Citations

125
COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study DOI Creative Commons
Miloslav Klugar, Abanoub Riad, Lekshmi Mohanan

et al.

Vaccines, Journal Year: 2021, Volume and Issue: 9(12), P. 1437 - 1437

Published: Dec. 6, 2021

The emerging SARS-CoV-2 variants and waning vaccine-elicited immunity are two public health challenges that occurred simultaneously synergistically during the summer of 2021 led to a surging demand for COVID-19 vaccine booster dose (BD) rollout. This study aimed evaluate hesitancy (VBH) among Czech healthcare workers explore potential determinants VBH. A national cross-sectional survey-based was carried out between 3 11 November 2021, using an online self-administered questionnaire (SAQ) explored participants' demographic characteristics, infection anamneses, willingness receive BD, psychosocial drivers total 3454 HCW properly responded SAQ, which 80.9% were females, 30.3% medical professionals, 50.5% ≤47 years old. Most participants already inoculated against (95.2%), BTN162b2 most commonly administered (90.7%). As sample planned represent target population, it revealed high level BD acceptance (71.3%) HCW, while 12.2% still hesitant 16.6% currently available BD. These results consistent with other recent from central Europe. Medical professional, male, older more likely accept rather than allied female, younger participants. BDs' perceived effectiveness severe illness, symptomatic infection, community transmission significant strong predictor acceptance, circulating not important our population. safety ethical dilemmas justice should be addressed sufficiently communicating population groups. altruistic reasons i.e., family protection, patient underpin recommendation postponing mandating in favour stressing these concerns amid messaging.

Language: Английский

Citations

107
COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 DOI Open Access
Stanley Xu, Runxin Huang, Lina S. Sy

et al.

MMWR Morbidity and Mortality Weekly Report, Journal Year: 2021, Volume and Issue: 70(43), P. 1520 - 1524

Published: Oct. 22, 2021

By September 21, 2021, an estimated 182 million persons in the United States were fully vaccinated against COVID-19.* Clinical trials indicate that Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273), and Janssen (Johnson & Johnson; Ad.26.COV2.S) vaccines are effective generally well tolerated (1-3). However, daily vaccination rates have declined approximately 78% since April 13, 2021†; vaccine safety concerns contributed to hesitancy (4). A cohort study of 19,625 nursing home residents found those who received mRNA (Pfizer-BioNTech or Moderna) had lower all-cause mortality than did unvaccinated (5), but no studies comparing within general population been conducted. To assess not associated with COVID-19 (non-COVID-19 mortality) after a setting, was conducted during December 2020-July 2021 among 11 enrolled seven Vaccine Safety Datalink (VSD) sites.§ After standardizing by age sex, this recipients non-COVID-19 persons. adjusting for demographic characteristics VSD site, adjusted relative risk (aRR) 0.41 (95% confidence interval [CI] = 0.38-0.44) dose 1 0.34 CI 0.33-0.36) 2. The aRRs 0.32-0.37) 0.31 0.30-0.33) aRR receipt 0.54 0.49-0.59). There is increased recipients. This finding reinforces profile currently approved States.

Language: Английский

Citations

100
Young Adult Perspectives on COVID-19 Vaccinations DOI Creative Commons
Sally Adams,

Jason P. Schaub,

Jason M. Nagata

et al.

Journal of Adolescent Health, Journal Year: 2021, Volume and Issue: 69(3), P. 511 - 514

Published: July 14, 2021

Language: Английский

Citations

90
Population preferences and attitudes towards COVID-19 vaccination: a cross-sectional study from Pakistan DOI Creative Commons
Muhammad Junaid Tahir, Muhammad Saqlain, Waleed Tariq

et al.

BMC Public Health, Journal Year: 2021, Volume and Issue: 21(1)

Published: Sept. 26, 2021

Abstract Background While vaccine development is itself a challenge; ensuring optimal uptake at population level can present an even more significant challenge. Therefore, this study aimed to assess the Pakistani population’s attitude and preferences towards Coronavirus disease 2019 (COVID-19) vaccine. Method A cross-sectional was carried out through online self-administered questionnaire from 27 September 2020 11 October 2020. total of 883 people responded survey. The included participants’ socio-demographic variables, attitudes, beliefs COVID-19 acceptance rejection vaccination, reasons for them. Logistic regression analysis used analyze predictors willingness pay Results majority (70.8%) respondents will accept COVID-19vaccine if available, 66.8% showed positive vaccination. Monthly family income, education level, self-diagnosis or friend, member, colleague are factors influencing dogma being naturally immune key reason refusal Less than half (48%) those who refuse vaccinate themselves government officials have made it compulsory. third (33.9%) participants were willing up (7 USD) 1000 Pkr (Pakistani Rupees) Conclusion should be improved by increasing awareness eradicating false myths about vaccines large-scale campaigns.

Language: Английский

Citations

82
Mapping global acceptance and uptake of COVID-19 vaccination: A systematic review and meta-analysis DOI Creative Commons
Qian Wang, Simeng Hu, Fanxing Du

et al.

Communications Medicine, Journal Year: 2022, Volume and Issue: 2(1)

Published: Sept. 12, 2022

The COVID-19 pandemic exit strategies depend on widespread acceptance of vaccines. We aim to estimate the global and uptake vaccination, their variations across populations, countries, time, sociodemographic subgroups.We searched four peer-reviewed databases (PubMed, EMBASE, Web Science, EBSCO) for papers published in English from December 1, 2019 February 27, 2022. This review included original survey studies which investigated or study quality was assessed using Appraisal tool Cross-Sectional Studies. reported pooled rates 95% confidence interval (CI) meta-analysis with a random-effects model.Among 15690 identified studies, 519 articles 7,990,117 participants are eligible meta-analysis. rate vaccination 67.8% (95% CI: 67.1-68.6) 42.3% 38.2-46.5), respectively. Among all population groups, pregnant/breastfeeding women have lowest (54.0%, 46.3-61.7) (7.3%, 1.7-12.8). varies ranging 35.9% (34.3-37.5) 86.9% (81.4-92.5) adults, is found Russia, Ghana, Jordan, Lebanon, Syria (below 50%). declines globally 2020, then recovers 2020 June 2021, further drops late 2021. Females, those aged < 60 years old, Black individuals, lower education income than counterparts. There large gaps (around 20%) between populations low income.COVID-19 vaccine needs be improved globally. Continuous monitoring necessary inform public health decision making.

Language: Английский

Citations

64
COVID-19 vaccine hesitancy among the adult population in Ghana: evidence from a pre-vaccination rollout survey DOI Creative Commons
Robert Kaba Alhassan, Matilda Aberese-Ako, Phidelia Theresa Doegah

et al.

Tropical Medicine and Health, Journal Year: 2021, Volume and Issue: 49(1)

Published: Dec. 1, 2021

Coronavirus disease 2019 (COVID-19) has already claimed over four million lives globally and 800 deaths in Ghana. The COVID-19 vaccine is a key intervention towards containing the pandemic. Over three billion doses of have been administered 800,000 Ghana, representing less than 5% vaccination coverage. Fear, uncertainty, conspiracy theories safety concerns remain important threats to, successful rollout if not managed well.Ascertain predictors citizens' probability participating trial subsequently accept when given opportunity.The study was an online nation-wide survey among community members (n = 1556) from 18th September to 23rd October, 2020 16 regions Binary probit regression analysis with marginal effect estimations employed ascertain members' willingness participate uptake vaccine.Approximately 60% respondents said they will trial; 65% take vaccine, while 69% recommend it others. Willingness voluntarily trial, advise others do same higher adults aged 18-48 years, unmarried males (p < 0.05). Significant unwillingness are: married persons, females, Muslims, older residents urbanised persons lower or no formal education Predominant reasons cited for included fear, concerns, lack trust state institutions, political connotations, spiritual religious beliefs.The accepting adult population Ghana high but country should get complacent because mistrust are that potential entrench hesitancy. campaigns be targeted cognisant perceptions vaccine. These lessons considered promote Ghana's efforts vaccinating at least 20 people attain herd immunity.

Language: Английский

Citations

57
Vaccine Hesitancy in the Time of COVID-19: Attitudes and Intentions of Teens and Parents Regarding the COVID-19 Vaccine DOI Creative Commons
Amy B. Middleman,

Judy Klein,

Jane Quinn

et al.

Vaccines, Journal Year: 2021, Volume and Issue: 10(1), P. 4 - 4

Published: Dec. 21, 2021

To assess attitudes and intentions related to the COVID-19 vaccine during pandemic, we surveyed adolescents aged 13–18 years parents of 13–18-year-olds using national research panels on three occasions or “waves”: before was available, after it available for adults, ages ≥12 years. Data experiences with COVID-19, importance adolescent vaccines, regarding vaccination were analyzed across time points. We found that parental concerns about safety significantly increased from Wave 1 2. Social media had a negative influence parents’ adolescents’ opinions safety. Demographic variables associated rates reported in 3, consistent known inequities access. Parents (70%) supportive concomitant other vaccines teens. It is important address hesitancy increase coverage US.

Language: Английский

Citations

56
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 DOI
Matthew G. Johnson,

Amy Puenpatom,

Pablo Andrés Moncada

et al.

Annals of Internal Medicine, Journal Year: 2022, Volume and Issue: 175(8), P. 1126 - 1134

Published: June 6, 2022

In the MOVe-OUT trial, molnupiravir showed a clinically meaningful reduction in risk for hospitalization or death adults with mild to moderate COVID-19 and factors progression severe disease.

Language: Английский

Citations

56
COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review DOI Creative Commons

Ebrahim Payberah,

Daniel Payberah,

Ashish Sarangi

et al.

Journal of the Egyptian Public Health Association, Journal Year: 2022, Volume and Issue: 97(1)

Published: Jan. 21, 2022

People with mental health problems are at particular risk both for infection COVID-19 and more severe course of illness. Understanding vaccine hesitancy is crucial in promoting acceptance among people diagnoses. This review aims to identify the prevalence discuss factors associated mentally ill population.We conducted a detailed literature search included 15 articles discussion this review. Several studies showed varying trends rates different countries. Major involved general include mistrust, misinformation, believing conspiracy theories, negative attitudes towards vaccines. It was surprising that none were focused on population. However, do show worse healthcare outcomes psychiatric patients, correlated lower likelihood receiving treatment vaccinations. Psychiatrists need address issues patients who particularly vulnerable fear vaccines which anxiety, panic attacks, certain phobias including trypanophobia agoraphobia, obsessive-compulsive disorder, types traumas. communicate effectively, respect, empathy, deliver accurate honest information about Motivational interviewing, getting illness organize campaigns, involving families may promote group.Existing limited. The increase especially having emotional disorders such as anxiety phobia. More addressing population be done future.

Language: Английский

Citations

55